Related Experiment Video

Updated: Jul 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Viruses as anticancer drugs

Stephen J Russell1, Kah-Whye Peng

  • 1Molecular Medicine Program, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. sjr@mayo.edu

Trends in Pharmacological Sciences
|June 19, 2007
PubMed

Insights

Oncolytic viruses are engineered to selectively destroy cancer cells. Overcoming antiviral immunity and studying their pharmacokinetics are key to developing these viruses as effective anticancer drugs.

Area of Science:

  • Oncology
  • Virology
  • Pharmacology

Background:

  • Oncolytic viruses are emerging as a promising class of anticancer therapeutics.
  • These viruses selectively replicate within tumor cells, leading to tumor destruction while sparing healthy tissues.
  • Their development as drugs necessitates rigorous safety and efficacy evaluations in human subjects.

Purpose of the Study:

  • To review the current concepts and strategies in the development of oncolytic viruses as anticancer drugs.
  • To highlight the importance of tumor-specific targeting mechanisms for enhanced safety.
  • To discuss the challenges and advancements in addressing antiviral immunity and enabling pharmacokinetic studies.

Main Methods:

  • Review of virus-engineering strategies for tumor specificity.
  • Discussion of immune-evasive delivery systems and immunosuppressive therapies.
  • Exploration of marker gene engineering for pharmacokinetic monitoring.

Main Results:

  • Virus engineering offers ingenious strategies to achieve neoplastic tissue specificity, crucial for safety.
  • Antiviral immunity presents a significant hurdle to clinical efficacy, being addressed by novel delivery and drug strategies.
  • Marker gene integration facilitates noninvasive pharmacokinetic monitoring, essential for drug development.

Conclusions:

  • Oncolytic virus therapy holds significant potential for cancer treatment.
  • Further research into targeting mechanisms, safety, efficacy, and pharmacokinetic studies is vital for clinical success.
  • Accelerating the development and approval of oncolytic viruses requires robust clinical data on their behavior in patients.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.